U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 19-25, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 19-25, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 05/20/2024
Location: Washington, DC
Subject: National Academies Public Workshop - Toward a Framework to Improve Diversity and Inclusion in Clinical Trials; Fireside Chat
FDA Participant/Group: NAMANDJE BUMPUS; MARY THANH HAI; JAMIE BREWER;
Non FDA Participant/Group: Academia, industry, government, media, and other registered attendees

Event Date: 05/22/2024
Location: Washington, DC
Subject: American Heart Association Centennial Advocacy Assembly
FDA Participant/Group: BETH FRITSCH; DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry, government, and other invited attendees

Event Date: 05/23/2024
Location: Virtual
Subject: Foundation for the National Institutes of Health (FNIH) Board of Directors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several FNIH board and leadership members

Event Date: 05/23/2024
Location: Silver Spring, MD
Subject: Food and Drug Administration Alumni Association Spring Fling
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Food and Drug Administration Alumni Association

Event Date: 05/24/2024
Location: Virtual
Subject: Safety of Food Chemicals
FDA Participant/Group: HAIDER WARRAICH; JAMES JONES;
Non FDA Participant/Group: Scott Faber (Environmental Working Group); Todd Wagner (2929 Entertainment);

Event Date: 05/24/2024
Location: Virtual
Subject: Stanford Physician Assistant Program: Panel on Essential Leadership Traits
FDA Participant/Group: N/A
Non FDA Participant/Group: Several students and faculty from Stanford University

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 05/20/2024
Location: Virtual
Subject: Food Safety Modernization Act (FSMA) Final Rule on Pre-Harvest Agricultural Water Webinar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and consumers

Event Date: 05/21/2024
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Members and staff from the Peanut and Tree Nut Processors Association

Event Date: 05/23/2024
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: KARI BARRETT;
Non FDA Participant/Group: Members and staff from the United Egg Producers

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/22/2024
Location: Washington, DC
Subject: American Heart Association (AHA) Centennial Advocacy Assembly Reception
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/23/2024
Location: Washington, DC
Subject: House Energy and Commerce Health Subcommittee Hearing; Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: House Energy and Commerce Health Subcommittee members and staff

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/19/2024
Location: Virtual
Subject: Innovative Regulation and Globalization of Cell and Gene Therapy Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Innovative Regulation and Globalization of Cell and Gene Therapy Meeting

Event Date: 05/20/2024
Location: Virtual
Subject: Drug Information Association China 2024 Annual Meeting; Advancing the Development of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Drug Information Association China 2024 Annual Meeting

Event Date: 05/21/2024
Location: Washington, DC
Subject: Everylife Foundation for Rare Diseases Scientific Workshop; Leaning Into Solutions: Implications for Innovation, Regulatory Practices, and Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Everylife Foundation for Rare Diseases Scientific Workshop

Event Date: 05/22/2024
Location: Virtual
Subject: 5th International Cell and Gene Therapy China Summit and Exhibition 2024; Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 5th International Cell and Gene Therapy China Summit and Exhibition 2024

Event Date: 05/23/2024
Location: Virtual
Subject: National Center for Advancing Translational Sciences Advisory Council Meeting; Advancing the Development of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Center for Advancing Translational Sciences Advisory Council Meeting

Event Date: 05/23/2024
Location: Orlando, FL
Subject: CureDuchenne FUTURES 2024 Meeting; Advancing the Development of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the CureDuchenne FUTURES 2024 Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 05/20/2024
Location: Virtual
Subject: Centers for Disease Control (CDC) All-State, Tribal, Local, and Territorial Update Call
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from National Association of State Departments of Agriculture (NASDA), Association of State and Territorial Health Officials (ASTHO), National Association of County and City Health Officials (NACCHO), Council of State and Territorial Epidemiologists (CSTE), Big Cities Health Coalition (BCHC), and Centers for Disease Control (CDC)

Event Date: 05/23/2024
Location: Virtual
Subject: H5N1 Briefing
FDA Participant/Group: NICHOLAS ALEXANDER;
Non FDA Participant/Group: Representatives from federal government and various state governments

Event Date: 05/23/2024
Location: Virtual
Subject: H5N1 Briefing
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from government and academia

Event Date: 05/23/2024
Location: Virtual
Subject: Flu Risk Management Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Centers for Disease Control (CDC), Health and Human Services (HHS), U.S. Department of Agriculture (USDA), Department of Homeland Security (DHS), National Institutes of Health (NIH), and Military Health System (MHS)

Event Date: 05/24/2024
Location: Virtual
Subject: Emerging Animal Health Event Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Association of State Departments of Agriculture (NASDA) and the National Assembly of State Animal Health Officials (NASAHO)

Event Date: 05/24/2024
Location: Virtual
Subject: Emerging Animal Health Event Industry Update
FDA Participant/Group: TRISTAN COLONIUS;
Non FDA Participant/Group: Industry

Event Date: 05/24/2024
Location: Virtual
Subject: Briefing on Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Centers for Disease Control (CDC), U.S. Department of Agriculture (USDA), and House and Senate Congressional Committee staff members

Event Date: 05/24/2024
Location: Virtual
Subject: Fresh Produce Coalition Monthly Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: De Ann Davis (Western Growers Association); Emily Moyer, Natalie Dyenson (International Fresh Produce Association (IFPA)); Barbara Kowalcyk (George Washington University (GWU)); Jennifer McEntire (Food Safety Strategy); Mike Taylor, Mitzi Baum (STOP Foodborne Illness (STOP)); Brian Ronholm (Consumer Reports); Hilary Thesmar (Food Marketing Institute (FMI)); Joe Reardon (National Association of State Departments of Agriculture (NASDA));

Event Date: 05/24/2024
Location: Virtual
Subject: Emerging Animal Health Event Briefing
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives for farm workers and rural health stakeholders

Event Date: 05/24/2024
Location: Virtual
Subject: Global Food Safety Institute (GFSI) Certificate Repository
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Consumer Goods Forum

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 05/19/2024
Location: San Diego, CA
Subject: American Thoracic Society (ATS) Regular Business Meeting; Speaker: FDA’s Comprehensive Approach to Tobacco Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the American Thoracic Society (ATS)

Event Date: 05/20/2024
Location: San Diego, CA
Subject: American Thoracic Society (ATS) Scientific Symposium; Speaker: Quitting is Winning: Tobacco and E-cigarette Cessation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the American Thoracic Society (ATS) and other conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top